Royal Bank of Canada
ROIV icon

Royal Bank of Canada’s Roivant Sciences ROIV Stock Holding History

Royal Bank of Canada’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$757K Sell
21,385
-88,656
-81% -$2.62M ﹤0.01% 4045
2026
Q1 		$3.05M Sell
110,041
-503,568
-82% -$12.9M ﹤0.01% 2783
2025
Q4 		$13.3M Sell
613,609
-1,909,460
-76% -$37.7M ﹤0.01% 1758
2025
Q3 		$38.2M Buy
2,523,069
+843,259
+50% +$10.4M 0.01% 1168
2025
Q2 		$18.9M Buy
1,679,810
+1,669,543
+16,261% +$18.1M ﹤0.01% 1569
2025
Q1 		$104K Sell
10,267
-17,726
-63% -$192K ﹤0.01% 5187
2024
Q4 		$332K Sell
27,993
-3,179
-10% -$37.6K ﹤0.01% 4405
2024
Q3 		$360K Sell
31,172
-4,721
-13% -$53.8K ﹤0.01% 4362
2024
Q2 		$380K Buy
35,893
+30,954
+627% +$339K ﹤0.01% 4229
2024
Q1 		$52K Sell
4,939
-79,914
-94% -$862K ﹤0.01% 5529
2023
Q4 		$953K Buy
84,853
+79,747
+1,562% +$777K ﹤0.01% 3704
2023
Q3 		$60K Buy
5,106
+896
+21% +$10.1K ﹤0.01% 5686
2023
Q2 		$43K Buy
4,210
+4,037
+2,334% +$36.1K ﹤0.01% 5841
2023
Q1 		$1K Sell
173
-669
-79% -$5.51K ﹤0.01% 6925
2022
Q4 		$7K Buy
+842
New +$4.68K ﹤0.01% 6663
2022
Q2 		– Sell
-6,065
Closed -$30K – 7663
2022
Q1 		$30K Buy
6,065
+6,055
+60,550% +$39.9K ﹤0.01% 6381
2021
Q4 		$0 Buy
+10
New +$83 ﹤0.01% 7856

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Royal Bank of Canada's ROIV Position: Q2 2026 in Review

Royal Bank of Canada reduced its Roivant Sciences (ROIV) stake by 81% in Q2 2026, selling an estimated $2.62M and leaving 21,385 shares worth $757K. The position accounts for ﹤0.01% of the portfolio, ranked #4045.

Royal Bank of Canada first reported a position in ROIV in Q4 2021 and has held it in 17 quarters since. The position peaked at $38.2M in Q3 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Royal Bank of Canada held 21,385 shares of Roivant Sciences worth $757K as of Q2 2026.
  • Royal Bank of Canada sold 88,656 Roivant Sciences shares in Q2 2026, an estimated $2.62M.
  • Roivant Sciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #4045 holding.
  • Royal Bank of Canada first reported a position in Roivant Sciences in Q4 2021 and has held it in 17 quarters since.
  • Royal Bank of Canada's Roivant Sciences position peaked at $38.2M in Q3 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.